Evidence map›Paper›PMID 42775336›Full record

ArticleCRSLS : MIS case reports from SLS

Robotic Splenectomy for Refractory Immune Thrombocytopenic Purpura.

Fernando Revoredo Rego, Mónica Uribe León, Lucía Ronceros Salas, Carlos Alberto Wong Chu

Abstract readCase Reports
In one paragraph

Article in CRSLS : MIS case reports from SLS. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fernando Revoredo RegoDepartment of General Surgery, Clínica Internacional, Lima, Perú. (Drs. Revoredo Rego, Uribe León, and Wong Chu).
Mónica Uribe LeónDepartment of General Surgery, Clínica Internacional, Lima, Perú. (Drs. Revoredo Rego, Uribe León, and Wong Chu).
Lucía Ronceros SalasDepartment of Hematology, Clínica Internacional, Lima, Perú. (Dr. Ronceros Salas).
Carlos Alberto Wong ChuDepartment of General Surgery, Clínica Internacional, Lima, Perú. (Drs. Revoredo Rego, Uribe León, and Wong Chu).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Splenectomy is a well-established surgical option for selected patients with immune thrombocytopenic purpura and persistent thrombocytopenia despite medical therapy. Although laparoscopic splenectomy remains the standard minimally invasive approach, robotic platforms may offer advantages in technically challenging cases. We present a 40-year-old woman with a 4-year history of immune thrombocytopenic purpura, obesity, Hashimoto thyroiditis, and prior sleeve gastrectomy presented with severe thrombocytopenia and abnormal uterine bleeding. After failure of medical therapy, she underwent robotic splenectomy with the da Vinci Xi robotic platform using an anterior approach. Operative time was 240 minutes, and estimated blood loss was 200 mL. The postoperative course was uneventful, and the patient was discharged on postoperative day 3. Pathologic examination findings were compatible with immune thrombocytopenic purpura. Robotic splenectomy is safe and feasible in this selected challenging case and may be considered an alternative minimally invasive approach when enhanced visualization and precise hilar dissection are desirable.

Indexed as

Purpura, Thrombocytopenic, IdiopathicRobotic Surgical ProceduresSplenectomyAdultFemaleHumansLaparoscopyImmune thrombocytopenic purpuraMinimally invasive surgical proceduresRobotic splenectomy

Identifiers

PMID42775336
PMCPMC13597004

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.